Stay updated on TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site release/version label on the page footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a platform change rather than an update to the trial’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T05:44:18.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2 in the page history.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:52.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added updated Study Status and Contacts/Locations sections (version 59, published 2026-03-25) and a deletion on 2026-02-17.
    Difference
    0.3%
    Check dated 2026-03-26T11:31:42.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 in the Record History.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:13.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 is added to the version history, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:37:22.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Results and related sections have been posted (Results, Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Study Status), and the prior 'Results Submitted' entry has been removed.
    Difference
    0.6%
    Check dated 2026-02-18T16:47:43.000Z thumbnail image

Stay in the know with updates to TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAR-200 Combo & Cetrelimab in Bladder Cancer Clinical Trial page.